Journal of Clinical Pathology and Laboratory Medicine

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Mini Review - Journal of Clinical Pathology and Laboratory Medicine (2023) Volume 5, Issue 5

Rheumatoid factor: A key marker in diagnosing rheumatoid arthritis

Debra Donnelly*

Department of Pathology, University of Warsaw, Poland

*Corresponding Author:
Debra Donnelly
Department of Pathology, University of Warsaw, Poland
University of Warsaw
Poland
E-mail:dedonly@pl

Received:26-Sept-2023, Manuscript No. AACPLM-23-115528; Editor assigned: 28-Sept-2023, PreQC No. AACPLM-23-115528(PQ); Reviewed:11-Oct-2023, QC No. AACPLM-23-115528; Revised:16-Oct-2023, Manuscript No. AACPLM-23-115528(R); Published:23-Oct-2023, DOI:10.35841/ aacplm-5.5.171

Citation: Donnelly D. Rheumatoid factor: A key marker in diagnosing rheumatoid arthritis. J Clin Path Lab Med. 2023;5(5):171

Introduction

Rheumatoid factor (RF) is an autoantibody that plays a crucial role in the diagnosis and management of several autoimmune diseases, with its most well-known association being Rheumatoid Arthritis (RA). This article explores the significance of RF, its relationship with various medical conditions, and its clinical relevance in the field of rheumatology. Rheumatoid factor is an antibody that targets other antibodies, specifically immunoglobulin G (IgG). It forms immune complexes with IgG molecules, leading to inflammation and tissue damage, particularly in the joints. RF is one of the hallmarks of rheumatoid arthritis, a chronic autoimmune disorder characterized by joint pain, swelling, and stiffness[1].

Early Detection: RF is a valuable diagnostic tool, especially in the early stages of RA. Its presence in the blood can signal the onset of the disease, allowing for prompt intervention and treatment. Monitoring Disease Activity: Rheumatologists use RF levels to assess the severity of RA and monitor disease activity over time. Higher RF titers often correlate with more aggressive disease and increased joint damage[2].

While RF is strongly associated with RA, it can also be detected in other medical conditions and in individuals without autoimmune diseases. These include: Other Autoimmune Diseases: RF may be found in conditions like Sjögren's syndrome, Systemic Lupus Erythematosus (SLE), and Mixed Connective Tissue Disease (MCTD), among others. However, it is not specific to any one autoimmune disorder. Infections: In some infections, particularly chronic viral infections like hepatitis C, individuals may produce RF as part of the immune response to the infection. Healthy Individuals: A small percentage of the general population may have low levels of RF without any autoimmune disease or infection. This is known as "seropositive" RF without clinical significance[3].

Clinical Utility of RF Testing: Diagnosis: RF testing is often included in the diagnostic workup of patients presenting with joint pain or other symptoms suggestive of autoimmune diseases, helping to distinguish between RA and other conditions. Monitoring Treatment: For patients diagnosed with RA, RF levels can be monitored to assess the response to treatment. Decreasing RF titers may indicate improved disease control. Prognostication: Elevated RF levels at the time of RA diagnosis may be associated with a poorer prognosis, including increased joint damage and disability[4].

Challenges and Considerations: It’s important to note that RF testing has limitations. RF can be found in conditions other than RA, and some individuals with RA may be "seronegative," meaning they do not have detectable RF in their blood. Therefore, RF testing is typically used in conjunction with other clinical and laboratory assessments to make a definitive diagnosis[5].

Conclusion

Rheumatoid factor is a critical component of autoimmune disease diagnosis, particularly in the case of rheumatoid arthritis. While its presence can signal the onset of RA and help monitor disease activity, RF testing must be interpreted alongside other clinical information and assessments to make accurate diagnoses and treatment decisions. Beyond RA, RF can also be detected in various autoimmune diseases and infections, making it a versatile marker in the realm of rheumatology and immunology.

References

  1. Dörner T, Egerer K, Feist E, et al. Rheumatoid factor revisited. Curr Opin Rheumatol. 2004;16(3):246-53.

    2. Indexed at, Google Scholar, Cross Ref

  2. Waaler E. On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles. Apmis. 2007;115(5):422-38.

    3. Indexed at, Google Scholar, Cross Ref

  3. Rose HM, Ragan C, Pearce E, et al. Differential agglutination of normal and sensitized sheep erythrocytes by sera of patients with rheumatoid arthritis. Proceedings of the Society for Experimental Biology and Medicine. 1948;68(1):1-6.

    4. Indexed at, Google Scholar, Cross Ref

  4. Pike RM, Sulkin SE, Coggeshall HC. Serological Reactions in Rheumatoid Arthritis: I. Factors Affecting the Agglutination of Sensitized Sheep Erythrocytes in Rheumatoid-Arthritis Serum. J Immunol. 1949;63(4):441-6.

    5. Indexed at, Google Scholar

  5. Ball J, Bloch KJ, Burch TA, Kellgren JH, Lawrence JS, Tsigalidou V. Comparative studies of serologic tests for rheumatoid disease. II. A comparison of the bentonite flocculation test and the sensitized sheep cell agglutination test. Journal of the American College of Rheumatology. 1962;5(1):61-9.

    6. Indexed at, Google Scholar, Cross Ref

Get the App